Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 5, Issue 9, Pages 1335-1350
Publisher
EMBO
Online
2013-07-19
DOI
10.1002/emmm.201302625
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GDNF-RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors
- (2013) A. Morandi et al. CANCER RESEARCH
- Outlier Kinase Expression by RNA Sequencing as Targets for Precision Therapy
- (2013) Vishal Kothari et al. Cancer Discovery
- Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions
- (2012) Y. Suehara et al. CLINICAL CANCER RESEARCH
- Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells
- (2012) Emma Sandilands et al. EMBO REPORTS
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- RET, ROS1 and ALK fusions in lung cancer
- (2012) Kengo Takeuchi et al. NATURE MEDICINE
- Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation Mechanism
- (2011) Iván Plaza-Menacho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- RET in breast cancer: functional and therapeutic implications
- (2011) Andrea Morandi et al. TRENDS IN MOLECULAR MEDICINE
- Estrogen-Dependent and Estrogen-Independent Mechanisms Contribute to AIB1-Mediated Tumor Formation
- (2010) M. I. Torres-Arzayus et al. CANCER RESEARCH
- Diverse somatic mutation patterns and pathway alterations in human cancers
- (2010) Zhengyan Kan et al. NATURE
- The FERM domain: organizing the structure and function of FAK
- (2010) Margaret C. Frame et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma
- (2010) J Kang et al. ONCOGENE
- Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance
- (2010) I Plaza-Menacho et al. ONCOGENE
- Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations
- (2009) Kristian Unger et al. ENDOCRINE-RELATED CANCER
- The Ret Receptor Tyrosine Kinase Pathway Functionally Interacts with the ER Pathway in Breast Cancer
- (2008) A. Boulay et al. CANCER RESEARCH
- Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer
- (2008) Y. Nikolsky et al. CANCER RESEARCH
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
- (2008) LANCET ONCOLOGY
- Tracing pathway activities with kinase inhibitors and reverse phase protein arrays
- (2008) Jan van Oostrum et al. Proteomics Clinical Applications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More